Misoprostol for cervical ripening and labor induction: A meta-analysis

被引:176
作者
SanchezRamos, L [1 ]
Kaunitz, AM [1 ]
Wears, RL [1 ]
Delke, I [1 ]
Gaudier, FL [1 ]
机构
[1] UNIV FLORIDA, HLTH SCI CTR, DEPT EMERGENCY MED, JACKSONVILLE, FL 32209 USA
关键词
D O I
10.1016/S0029-7844(96)00374-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To analyze published randomized trials assessing the safety and efficacy of misoprostol for cervical ripening and labor induction. Data Sources: We supplemented a search of entries in electronic data bases with references cited in original studies and review articles to identify randomized trials of misoprostol for cervical ripening and labor induction. Methods of Study Selection: Two blinded investigators performed independent trial quality evaluation and data abstraction of randomized clinical trials assessing the efficacy of misoprostol as a cervical ripening and labor-inducing agent. Tabulation, Integration, and Results: We calculated an estimate of the odds ratio (OR) and risk difference for dichotomous outcomes, using both a random- and fixed-effects model. Continuous outcomes were pooled using a variance-weighted average of the within-study difference in means. Of 16 studies identified, eight met our criteria for meta-analysis. These eight trials included 966 patients (488 received misoprostol and 478 were controls). Women who received misoprostol for cervical ripening and labor induction had a significantly lower overall cesarean rate (OR 0.67, 95% confidence interval [CI] 0.48, 0.93) and a higher incidence of vaginal delivery within 24 hours of misoprostol application (OR 2.64, 95% CI 1.87, 3.71). Use of misoprostol was associated with a higher incidence of tachysystole (OR 2.70, 95% CI 1.80, 4.04) but not hyperstimulation (OR 1.91, 95% CI 0.98, 3.73). The incidences of abnormal 5-minute Apgar scores and admissions to the neonatal intensive care unit were similar in the misoprostol and control groups. The pooled estimate of the mean interval from start of induction to delivery was 4.6 hours fewer (95% CI -3.5, -5.7) in the misoprostol group. Conclusion: Published data confirm the safety and efficacy of intravaginal misoprostol as an agent for cervical ripening and labor induction. (C) 1997 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:633 / 642
页数:10
相关论文
共 41 条
[1]  
*AM COLL OBST GYN, 1995, ACOG TECHN B, V217
[2]  
*AM COLL OBST GYN, 1993, ACOG COMM OP, V123
[3]  
[Anonymous], 1980, STAT METHODS CANC RE
[4]  
BERNSTEIN P, 1991, CAN MED ASSOC J, V145, P1249
[5]  
Brindley B A, 1988, Obstet Gynecol Surv, V43, P730, DOI 10.1097/00006254-198812000-00004
[6]   INDUCTION OF LABOR WITH INTRAVAGINAL MISOPROSTOL IN INTRAUTERINE FETAL DEATH [J].
BUGALHO, A ;
BIQUE, C ;
MACHUNGO, F ;
FAUNDES, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (02) :538-541
[7]   A COMPARATIVE-STUDY OF VAGINAL MISOPROSTOL AND INTRAVENOUS OXYTOCIN FOR INDUCTION OF LABOR [J].
BUGALHO, A ;
BIQUE, C ;
MACHUNGO, F ;
BERGSTROM, S .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1995, 39 (04) :252-256
[8]   VAGINAL MISOPROSTOL AS AN ALTERNATIVE TO OXYTOCIN FOR INDUCTION OF LABOR IN WOMEN WITH LATE FETAL DEATH [J].
BUGALHO, A ;
BIQUE, C ;
MACHUNGO, F ;
BERGSTROM, S .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1995, 74 (03) :194-198
[9]   LOW-DOSE VAGINAL MISOPROSTOL FOR INDUCTION OF LABOR WITH A LIVE FETUS [J].
BUGALHO, A ;
BIQUE, C ;
MACHUNGO, F ;
FAUNDES, A .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1995, 49 (02) :149-155
[10]  
Bugnon A, 1994, Ginecol Obstet Mex, V62, P407